Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia (DREAM)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Willem-Peter Theodoor Ruifrok, University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT00524901
First received: September 4, 2007
Last updated: February 13, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)